Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/2010
11/30/2010US7842478 DNA encoding mammalian phosphodiesterases
11/30/2010US7842476 In vitro peptide expression library
11/30/2010US7842470 Method for pharmacoperones correction of GnRHR mutant protein misfolding
11/30/2010US7842458 Amino acid sequences for use in diagnosis, prevention and detection of cancer
11/30/2010US7842453 Methods of identifying modulators of ChemerinR polypeptides
11/30/2010US7842330 Process for preparation of flax protein isolate
11/30/2010US7842298 Hepatitis virus for use in the diagnosis and prevention of viral diseases in birds and humans; polynucleotide consisting of the nucleotide sequence of the ORF2 gene of an avian hepatitis E virus or its complementary strand
11/30/2010US7842297 raising an antibody specific for Chlamydia trachomatis elementary bodies (EB) in which a protein of the present invention is administered to a patient
11/30/2010US7842296 Sequences from Piscirickettsia salmonis
11/30/2010US7842294 useful in vaccine compositions for treatment of cancer; human major histocompatibility complex (MHC) Class I restricted peptides; kits
11/30/2010US7842290 involved in the adaptation of microorganisms to its environment, particularly the identification of genes responsible for the virulence of a pathogenic microorganisms
11/30/2010US7842289 Polypeptides; antigens; vaccines; fusion protein containing signal peptide and polypeptide; genetic engineered Listeria bacteria
11/30/2010US7842187 From Moraxella catarrhalis outer membrane proteins; ultrafiltration
11/30/2010CA2430772C Humanized antibodies that recognize beta amyloid peptide
11/30/2010CA2338093C Vaccines against escherichia coli o157 infection
11/30/2010CA2295876C Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases
11/30/2010CA2259595C Dna immunization against chlamydia infection
11/30/2010CA2189740C Transgenic arthritic mice
11/25/2010WO2010135749A1 Herpes simplex virus type2: compositions and methods for eliciting an immune response
11/25/2010WO2010135728A2 Extracellular plant ferredoxin-like protein and uses thereof
11/25/2010WO2010135704A2 Secretion-related bacterial proteins for nlrc4 stimulation
11/25/2010WO2010135655A2 Human skin substitutes expressing il-12
11/25/2010WO2010135639A2 Compositions and methods for promoting beta cell maturity
11/25/2010WO2010135585A2 Engineered type iv pilin of clostridium difficile
11/25/2010WO2010135541A2 Variants of c-type natriuretic peptide
11/25/2010WO2010135491A2 Fibroblast growth factor mutants having improved functional half-life and methods of their use
11/25/2010WO2010135391A2 An improved method for diagnosing or predicting short stature in humans
11/25/2010WO2010135054A2 Mutations in a toll-like receptor motif in the ns4b of classical swine fever virus skin brescia influences virulence in swine
11/25/2010WO2010134970A1 Inhibition of prion protein propagation by receptor associated protein (rap). its derivatives, mimetics and syntentic peptides
11/25/2010WO2010134686A2 Soluble myostatin pro-domain recombinant protein having myostatin inhibitory activity and use thereof
11/25/2010WO2010134654A1 Transcription factor ap37 increasing resistance of plants against drought stress, and use thereof
11/25/2010WO2010134601A1 Peptide inducing xage-1b-specific immune reaction and utilization of same
11/25/2010WO2010134308A1 Biomarker for mental disorders including cognitive disorders, and method using said biomarker to detect mental disorders including cognitive disorders
11/25/2010WO2010134305A1 Peptidic antigen that induces antibody recognizing three-dimensional structure of hiv and method for synthesizing same
11/25/2010WO2010134140A1 Method for placing ferritin
11/25/2010WO2010134139A1 Method for placing ferritin
11/25/2010WO2010134096A2 Yeast strain expressing modified human cytochrome p450 reductase and/or cytochrome p450 gene
11/25/2010WO2010134095A2 Yeast strain expressing modified human cytochrome p450 reductase and/or cytochrome p450 gene
11/25/2010WO2010134084A1 A method of purifying human growth hormone and purified growth hormone thereof
11/25/2010WO2010133828A1 Bifunctional polypeptides
11/25/2010WO2010133543A2 Process to produce a wine or fruit juice stabiliser
11/25/2010WO2010133194A1 Microorganism for expressing a human membrane protein
11/25/2010WO2010133071A1 Highly purified follicle stimulating hormone from urea and method for preparing thereof
11/25/2010WO2010132988A1 Increased seed oil and abiotic stress tolerance mediated by plant chd3 protein
11/25/2010WO2010115586A3 Method for purifying recombinant fsh
11/25/2010WO2010090834A3 Netrin-1 as a biomarker of injury and disease
11/25/2010WO2010086294A3 Pan-dr binding polypeptides and uses thereof
11/25/2010WO2010085151A3 Means and methods for modulating notch3 protein expression and/or the coding region of notch3; compositions and use thereof in the treatment of cadasil
11/25/2010WO2010085114A3 Abscisic acid carrier gene and transgenic plant expressing same
11/25/2010WO2010080994A3 Process for regulating immune response
11/25/2010WO2010080007A3 Lipoproteins derived from gram-positive bacteria functioning as toll-like receptor 2 ligand
11/25/2010WO2010068777A3 Materials and methods for modulating plant photosynthetic capacity and biomass
11/25/2010WO2010062903A3 Genomic sequencing using modified protein pores and ionic liquids
11/25/2010WO2010056808A3 Compositions and methods for re-programming and re-differentiating cells
11/25/2010WO2010048615A3 Human ebola virus species and compositions and methods thereof
11/25/2010WO2010040003A3 Human a2a adenosine receptor crystals and uses thereof
11/25/2010WO2009136352A8 Anti-angiogenic compounds
11/25/2010WO2009131548A8 Multimeric forms of antimicrobial peptides
11/25/2010US20100299789 improved ability to enzymatically degrade lignocellulosic feedstocks; fermentation
11/25/2010US20100299782 Plant co2 sensors, nucleic acids encoding them, and methods for making and using them
11/25/2010US20100299776 Soybean cultivar 8023330
11/25/2010US20100299774 Soybean cultivar 8837234
11/25/2010US20100299769 Novel peptide involved in energy homeostasis
11/25/2010US20100298877 Recombinant Spider Silk Proteins
11/25/2010US20100298546 Dnas encoding tnf receptor family members
11/25/2010US20100298543 Mammalian zcytor 11
11/25/2010US20100298541 Protein Scaffolds
11/25/2010US20100298540 Crystal Structure of a MarR Family Polypeptide
11/25/2010US20100298539 Novel polypeptides and use thereof
11/25/2010US20100298535 Pmma binding peptides
11/25/2010US20100298534 Pmma binding peptides
11/25/2010US20100298533 Pmma binding peptides
11/25/2010US20100298532 Pmma binding peptides
11/25/2010US20100298531 Pmma binding peptides
11/25/2010US20100298529 Manufacture and use of modified polysaccharide chitosan bonds and a process to improve the preparation of hes-medicinal substance compounds
11/25/2010US20100298528 Cystine knot molecules
11/25/2010US20100298419 Antibiotic-free plasmid
11/25/2010US20100298415 Targeted schiff base complexes
11/25/2010US20100298414 Development of a preventive vaccine for filovirus infection in primates
11/25/2010US20100298404 Translocation and mutant ROS kinase in human non-small cell lung carcinoma
11/25/2010US20100298241 Pmma binding peptides
11/25/2010US20100298240 Pmma binding peptides
11/25/2010US20100298239 Peptide with multiple epitopes
11/25/2010US20100298238 Nontoxic shiga-like toxin mutant compositions and methods
11/25/2010US20100298236 Soluble gp130 muteins with improved binding activity
11/25/2010US20100298234 Cancer therapeutic agents comprising a ligand for the neuromedin u receptor 2 (fm4) molecule as an active ingredient
11/25/2010US20100298232 Peptides targeting TNF family receptors and antagonizing TNF action, compositions, methods and uses thereof
11/25/2010US20100298231 Pmma binding peptides
11/25/2010US20100298229 Osteoprotegerin
11/25/2010US20100298226 Polypeptides and polynucleotides encoding same and use thereof in the treatment of medical conditions associated with ischemia
11/25/2010US20100298225 Peptide gap junction modulators
11/25/2010US20100298224 Use of mutated antithrombins for treating or preventing coagulation disorders
11/25/2010US20100298220 Fibroblast growth factor mutants having improved functional half-life and methods of their use
11/25/2010US20100298218 Single Branch Heparin-Binding Growth Factor Analogs
11/25/2010US20100298217 Csf-1r mutants
11/25/2010US20100298216 Casein Derived Peptides And Uses Thereof in Therapy
11/25/2010US20100298213 Pharmaceutically Active Insulin Receptor-Modulating Molecules
11/25/2010US20100298212 Modified Insulin Polypeptides and Their Uses
11/25/2010US20100298211 Axmi-001, axmi-002, axmi-030, axmi-035, and axmi-045: toxin genes and methods for their use
11/25/2010US20100298207 Pesticidal proteins and methods for their use
1 ... 446 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 ... 2916